Your browser doesn't support javascript.
loading
Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients.
Fiorino, G; Correale, C; Radice, S; Allocca, M; Furfaro, F; Gilardi, D; Nagore, D; Del Rio, L; Pascual, J; Martínez, A; Danese, S.
Afiliación
  • Fiorino G; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Correale C; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Radice S; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Allocca M; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Furfaro F; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Gilardi D; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Nagore D; R&D Department, Progenika SA, Derio, Spain.
  • Del Rio L; R&D Department, Progenika SA, Derio, Spain.
  • Pascual J; R&D Department, Progenika SA, Derio, Spain.
  • Martínez A; R&D Department, Progenika SA, Derio, Spain.
  • Danese S; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
Aliment Pharmacol Ther ; 46(9): 903-905, 2017 11.
Article en En | MEDLINE | ID: mdl-29023889
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infliximab / Anticuerpos Monoclonales Límite: Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2017 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infliximab / Anticuerpos Monoclonales Límite: Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2017 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido